bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Syndax Pharmaceuticals Inc. logo

    Syndax Pharmaceuticals Inc.

    SNDX | NASDAQ
    Chart Builder DCF Calculator
    $18.28
    +$0.21 (+1.16%)
    Sep 22, 2026, 10:40 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.6B
    Enterprise Value
    $1.64B
    Beta
    0.37
    Average Volume
    1.75M
    Shares Outstanding (Diluted)
    88.99M
    Shares Change YoY
    3.07%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US87164F1057

    Price Performance

    Price Change 1M
    -8.1%
    Price Change 3M
    -7.8%
    Price Change 6M
    -25.3%
    Price Change YTD
    -15.2%
    Price Change 1Y
    21.4%
    Price Change 3Y
    13.2%
    Price Change 5Y
    -3.9%
    1M CAGR (ann.)
    -11.4%
    1Y CAGR (ann.)
    17.0%
    5Y CAGR (ann.)
    -0.9%
    All-Time CAGR
    4.0%

    Valuation

    PE Ratio
    -7.17
    Forward PE
    269.11
    PEG Ratio
    -0.15
    Forward PEG
    0.12
    PS Ratio
    6.35
    Forward PS
    3.50
    PB Ratio
    106.05
    P/FCF Ratio
    -5.90
    P/Adj. FCF Ratio
    -4.81
    P/OCF Ratio
    -7.29
    EV/Sales
    6.52
    EV/EBIT
    -12.14
    EV/EBITDA
    -12.15
    EV/FCF
    -6.06
    Earnings Yield
    -13.9%
    FCF Yield
    -16.9%
    Adj. FCF Yield
    -20.8%

    Financial Health

    Net Debt
    $40.26M
    Total Debt
    $589.38M
    Cash & Short-Term Investments
    $547.86M
    Total Assets
    $703.65M
    Current Ratio
    6.77
    Quick Ratio
    6.44
    Debt / Equity Ratio
    39.03
    Debt / EBITDA
    -4.36
    Debt / FCF
    -2.17
    OCF / Debt
    -0.46
    Interest Coverage
    -2.27
    Altman Z-Score
    -1.08
    Piotroski F-Score
    5

    Margins & Profitability

    Gross Profit Margin
    97.5%
    Operating Profit Margin
    -77.0%
    EBITDA Margin
    -53.7%
    Net Profit Margin
    -87.6%
    FCF Margin
    -107.6%
    Adj. FCF Margin
    -132.0%
    SBC / Revenue
    19.6%
    SBC Impact (per share)
    -22.7%

    Returns

    Return on Assets
    -31.4%
    Return on Equity
    -372.9%
    Return on Invested Capital
    -32.1%
    Return on Capital Employed
    -32.1%
    Return on Tangible Assets
    -31.4%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    111.7%
    Revenue CAGR 5Y
    178.0%
    Revenue CAGR 10Y
    70.4%
    EPS CAGR 3Y
    13.2%
    EPS CAGR 5Y
    -28.3%
    EPS CAGR 10Y
    -2.1%
    FCF CAGR 3Y
    -5.5%
    FCF CAGR 5Y
    -37.2%
    FCF CAGR 10Y
    -23.0%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    22
    EPS Growth Next 3Y
    60.3%
    Revenue Growth Next 3Y
    52.2%
    Earnings Date
    Nov 1, 2026
    EPS Estimate (next Q)
    -$0.51
    EPS Growth Est (next Q)
    -27.1%
    Revenue Est (next Q)
    $82.79M
    Revenue Growth Est (next Q)
    80.5%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $37
    Price Target Upside
    104.8%

    Cash Flow

    Operating Cash Flow
    $-270.99M
    Free Cash Flow
    $-271.21M
    Adj. Free Cash Flow
    $-332.67M
    FCF Per Share
    -$2.48
    OCF Per Share
    -$2.48
    OCF/S Ratio
    -87.6%

    Income Statement

    Revenue
    $252M
    Gross Profit
    $245.64M
    Operating Income
    $-194.17M
    EBITDA
    $-135.25M
    Net Income
    $-220.77M
    EPS (Diluted)
    -$2.52
    Revenue / Employee
    $845.65K
    Profit / Employee
    $-740.82K
    Employees
    298

    © 2026 bestshares.com. All rights reserved.